Kastelein Johannes Jacob Pieter 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Kastelein Johannes Jacob Pieter（CIK 2000389）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 买入 | 50,246 | $0 |
| 2026-10-02 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 50,246 | $1.3M |
| 2026-08-25 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 买入 | 125,000 | $0 |
| 2026-08-25 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 125,000 | $3.4M |
| 2026-03-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 买入 | 104,467 | $0 |
| 2026-03-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 104,467 | $3.2M |
| 2026-03-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 买入 | 94,124 | $0 |
| 2026-03-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 94,124 | $2.9M |
| 2026-03-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 买入 | 101,409 | $0 |
| 2026-03-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 101,409 | $3.1M |
| 2026-02-24 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 14,692 | $514,220 |
| 2026-02-24 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 30,789 | $1.1M |
| 2026-01-07 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 6,000 | $199,500 |
| 2026-01-07 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 买入 | 25,500 | $0 |
| 2025-08-25 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 50,000 | $1.2M |
| 2025-08-25 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 42,342 | $1.1M |
| 2025-08-25 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer | 卖出 | 7,658 | $195,202 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02